[{"address1": "5217 Winnebago Lane", "city": "Austin", "state": "TX", "zip": "78744", "country": "United States", "phone": "512 386 2900", "website": "https://www.xbiotech.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.", "fullTimeEmployees": 94, "companyOfficers": [{"maxAge": 1, "name": "Mr. John  Simard", "age": 61, "title": "Founder, President, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 5556481, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela  Hu", "age": 39, "title": "Director of Finance", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 198133, "exercisedValue": 0, "unexercisedValue": 1200}, {"maxAge": 1, "name": "Dr. Sushma  Shivaswamy Ph.D.", "age": 45, "title": "Chief Scientific Officer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 449990, "exercisedValue": 0, "unexercisedValue": 4000}], "auditRisk": 10, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 5, "overallRisk": 8, "governanceEpochDate": 1727740800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 6.97, "open": 7.02, "dayLow": 6.74, "dayHigh": 7.49, "regularMarketPreviousClose": 6.97, "regularMarketOpen": 7.02, "regularMarketDayLow": 6.74, "regularMarketDayHigh": 7.49, "exDividendDate": 1626307200, "beta": 1.408, "forwardPE": 57.307693, "volume": 34603, "regularMarketVolume": 34603, "averageVolume": 55871, "averageVolume10days": 31840, "averageDailyVolume10Day": 31840, "bid": 5.32, "ask": 8.84, "bidSize": 200, "askSize": 200, "marketCap": 226950832, "fiftyTwoWeekLow": 3.51, "fiftyTwoWeekHigh": 9.96, "fiftyDayAverage": 6.736, "twoHundredDayAverage": 6.66455, "currency": "USD", "enterpriseValue": 48420512, "floatShares": 19828164, "sharesOutstanding": 30463200, "sharesShort": 925372, "sharesShortPriorMonth": 852308, "sharesShortPreviousMonthDate": 1724976000, "dateShortInterest": 1727654400, "sharesPercentSharesOut": 0.0304, "heldPercentInsiders": 0.3513, "heldPercentInstitutions": 0.15068, "shortRatio": 17.11, "shortPercentOfFloat": 0.0519, "bookValue": 6.457, "priceToBook": 1.1537865, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -35007000, "trailingEps": -1.16, "forwardEps": 0.13, "enterpriseToEbitda": -1.175, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "XBIT", "underlyingSymbol": "XBIT", "shortName": "XBiotech Inc.", "longName": "XBiotech Inc.", "firstTradeDateEpochUtc": 1429104600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "fb07a30b-f4ae-35af-9fbb-83dba861caeb", "gmtOffSetMilliseconds": -14400000, "currentPrice": 7.45, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 188530000, "totalCashPerShare": 6.189, "ebitda": -41192000, "totalDebt": 10000000, "quickRatio": 11.061, "currentRatio": 11.126, "debtToEquity": 5.084, "returnOnAssets": -0.119049996, "returnOnEquity": -0.16444, "freeCashflow": -18405124, "operatingCashflow": -23498000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-14"}]